Oh, T., Pelcovits, A., Grover, N., Thomas, C., Tiger, Y. K., Cortese, M., Davis, J., Kidwell, A., Moyo, T., Fitzgerald, L., Cohen, J., Melody, M., Shah, N., Kenkre, V., Hess, B., Ollila, T., Herr, M., Shouse, G., Mubeen, S., Elghawy, O., Antonio, D., Kerr, D., Lee, C., Moreira, J., Ma, S., Winter, J., Shah, N., Gordon, L., Epperla, N., Stephens, D., Karmali, R. (2025). Outcomes of patients with Relapsed/Refractory aggressive B-cell lymphoma receiving bispecific antibody therapy as monotherapy or in combination with targeted therapy. Blood. https://doi.org/10.1182/blood-2025-4551